154 related articles for article (PubMed ID: 30095576)
1. Increasing Vitamin D Serum Levels Is Associated With Reduced Pulmonary Exacerbations in Patients With Cystic Fibrosis.
Abu-Fraiha Y; Elyashar-Earon H; Shoseyov D; Cohen-Cymberknoh M; Armoni S; Kerem E; Wilschanski M
J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):110-115. PubMed ID: 30095576
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial.
Pincikova T; Paquin-Proulx D; Sandberg JK; Flodström-Tullberg M; Hjelte L
Eur J Clin Nutr; 2017 Feb; 71(2):203-205. PubMed ID: 27966575
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D intake, serum 25-hydroxy vitamin D and pulmonary function in paediatric patients with cystic fibrosis: a longitudinal approach.
Timmers NKLM; Stellato RK; van der Ent CK; Houwen RHJ; Woestenenk JW
Br J Nutr; 2019 Jan; 121(2):195-201. PubMed ID: 30442206
[TBL] [Abstract][Full Text] [Related]
4. Association between serum 25-hydroxyvitamin D level and pulmonary exacerbations in cystic fibrosis.
Vanstone MB; Egan ME; Zhang JH; Carpenter TO
Pediatr Pulmonol; 2015 May; 50(5):441-6. PubMed ID: 25657016
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of inadequate vitamin d status and associated factors in children with cystic fibrosis.
Norton L; Page S; Sheehan M; Mazurak V; Brunet-Wood K; Larsen B
Nutr Clin Pract; 2015 Feb; 30(1):111-6. PubMed ID: 25550329
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D status correlates with the markers of cystic fibrosis-related pulmonary disease.
Wani WA; Nazir M; Bhat JI; Malik EU; Ahmad QI; Charoo BA; Ali SW
Pediatr Neonatol; 2019 Apr; 60(2):210-215. PubMed ID: 30093293
[TBL] [Abstract][Full Text] [Related]
7. Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis.
Stephenson A; Brotherwood M; Robert R; Atenafu E; Corey M; Tullis E
Am J Clin Nutr; 2007 May; 85(5):1307-11. PubMed ID: 17490967
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D deficiency is associated with pulmonary dysfunction in cystic fibrosis.
Sexauer WP; Hadeh A; Ohman-Strickland PA; Zanni RL; Varlotta L; Holsclaw D; Fiel S; Graff GR; Atlas A; Bisberg D; Hadjiliadis D; Michel SH; Mintz D; Chakraborty R; Marra B; Lomas P; Ward T; Sassman M; Imbesi GC; Kitch DM; Mallowe AM
J Cyst Fibros; 2015 Jul; 14(4):497-506. PubMed ID: 25577127
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency in pediatric patients with cystic fibrosis: associated risk factors in the northern United States.
Lansing AH; McDonald C; Patel RA; Meihls S; Crowell K; Chatfield B; Pohl JF
South Med J; 2015 Mar; 108(3):164-9. PubMed ID: 25772050
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency is associated with pulmonary exacerbations in children with cystic fibrosis.
McCauley LA; Thomas W; Laguna TA; Regelmann WE; Moran A; Polgreen LE
Ann Am Thorac Soc; 2014 Feb; 11(2):198-204. PubMed ID: 24083951
[TBL] [Abstract][Full Text] [Related]
11. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation.
Tangpricha V; Kelly A; Stephenson A; Maguiness K; Enders J; Robinson KA; Marshall BC; Borowitz D;
J Clin Endocrinol Metab; 2012 Apr; 97(4):1082-93. PubMed ID: 22399505
[TBL] [Abstract][Full Text] [Related]
12. Association between hypovitaminosis D and frequency of pulmonary exacerbations in children and adolescents with cystic fibrosis.
Ongaratto R; Rosa KMD; Eloi JC; Epifanio M; Marostica P; Pinto LA
Einstein (Sao Paulo); 2018; 16(1):eAO4143. PubMed ID: 29694616
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D for the Immune System in Cystic Fibrosis (DISC): a double-blind, multicenter, randomized, placebo-controlled clinical trial.
Tangpricha V; Lukemire J; Chen Y; Binongo JNG; Judd SE; Michalski ES; Lee MJ; Walker S; Ziegler TR; Tirouvanziam R; Zughaier SM; Chesdachai S; Hermes WA; Chmiel JF; Grossmann RE; Gaggar A; Joseph PM; Alvarez JA
Am J Clin Nutr; 2019 Mar; 109(3):544-553. PubMed ID: 30793177
[TBL] [Abstract][Full Text] [Related]
14. Extra-skeletal impact of vitamin D supplementation protocol in an adult population with cystic fibrosis.
Lehoux Dubois C; Labrèche E; Boudreau V; Colomba J; Mailhot M; Lavoie A; Rabasa-Lhoret R; Coriati A
Clin Nutr; 2019 Aug; 38(4):1666-1671. PubMed ID: 30190118
[TBL] [Abstract][Full Text] [Related]
15. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis.
Hakim F; Kerem E; Rivlin J; Bentur L; Stankiewicz H; Bdolach-Abram T; Wilschanski M
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):347-53. PubMed ID: 17873748
[TBL] [Abstract][Full Text] [Related]
16. Association of vitamin D status with lung function measurements in children and adolescents with cystic fibrosis.
Loukou I; Moustaki M; Sardeli O; Plyta M; Douros K
Pediatr Pulmonol; 2020 Jun; 55(6):1375-1380. PubMed ID: 31338968
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.
Simoneau T; Sawicki GS; Milliren CE; Feldman HA; Gordon CM
J Cyst Fibros; 2016 Mar; 15(2):234-41. PubMed ID: 26211605
[TBL] [Abstract][Full Text] [Related]
18. Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis.
West NE; Lechtzin N; Merlo CA; Turowski JB; Davis ME; Ramsay MZ; Watts SL; Stenner SP; Boyle MP
Chest; 2011 Aug; 140(2):469-474. PubMed ID: 21393390
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Status and Risk of Cystic Fibrosis-Related Diabetes: A Retrospective Single Center Cohort Study.
Peng Y; Wu M; Alvarez JA; Tangpricha V
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836301
[TBL] [Abstract][Full Text] [Related]
20. Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure.
Cairoli E; Eller-Vainicher C; Morlacchi LC; Tarsia P; Rossetti V; Pappalettera M; Arosio M; Chiodini I; Blasi F
Osteoporos Int; 2019 Jun; 30(6):1255-1263. PubMed ID: 30798331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
